Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-17 · accession 0001140361-23-025743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | RCKT | Patel Kinnari | See Remarks | S - Sale | $21.38 | -1,330 | 214.0K | -0.6% | -$28.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | S | D | 1,330 | $21.38 | 213,993 | D | — | — | (F1) The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. |